Skip to content

Clinical trials

Completed Phase 3 trials in Kazakhstan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 3 Status: Completed Country / region: Kazakhstan Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20123
20132
20143
20151
20163
20172
20183
20191
20206
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche5
Takeda3
AbbVie2
Médecins Sans Frontières, France2
Research Institute for Biological Safety Problems2
AKARI Therapeutics1
Altaco XXI, LLP1
Astana Medical University1
Astellas Pharma Europe Ltd.1
Bayer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke3
Tuberculosis3
Tuberculosis, Multidrug-Resistant3
Arthritis2
Arthritis, Rheumatoid2
Bacterial Infections2
Joint Diseases2
Musculoskeletal Diseases2
Tuberculosis, Pulmonary2
Alcoholism1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.